NanoViricides
NNVC
#10057
Rank
ยฃ20.84 M
Marketcap
ยฃ0.97
Share price
4.88%
Change (1 day)
-17.12%
Change (1 year)

NanoViricides (NNVC) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.84 Million

According to NanoViricides's latest financial reports the company has ยฃ0.84 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NanoViricides - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30ยฃ3.79 M-40.83%
2023-06-30ยฃ6.41 M-44.57%
2022-06-30ยฃ11.56 M-22.03%
2021-06-30ยฃ14.83 M34.08%
2020-06-30ยฃ11.06 M449.72%
2019-06-30ยฃ2.01 M-62.46%
2018-06-30ยฃ5.36 M-53.82%
2017-06-30ยฃ11.6 M-35.96%
2016-06-30ยฃ18.12 M-9.63%
2015-06-30ยฃ20.05 M-6.47%
2014-06-30ยฃ21.44 M134.22%
2013-06-30ยฃ9.15 M0.64%
2012-06-30ยฃ9.09 M58.3%
2011-06-30ยฃ5.74 M25.32%
2010-06-30ยฃ4.58 M347.34%
2009-06-30ยฃ1.02 M149.97%
2008-06-30ยฃ0.41 M-15.15%
2007-06-30ยฃ0.48 M-64.75%
2006-06-30ยฃ1.37 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
BioCryst Pharmaceuticals
BCRX
ยฃ0.15 B 18,810.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.57 B 67,670.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ5.50 B 652,732.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.36 B 1,465,819.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ13.64 B 1,617,901.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ3.32 B 394,706.83%๐Ÿ‡ฌ๐Ÿ‡ง UK